Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Lactobacillus helveticus Rosell-52

What does the research say about Lactobacillus helveticus Rosell-52?

3 health outcomes synthesised

Lactobacillus helveticus Rosell-52 is a probiotic strain researched for its potential effects on mental health and cognitive outcomes. Across three health outcomes (reduced depression symptoms, improved cognitive function, and improved mental health), the strongest evidence base is for reducing depression symptoms, drawing from 4 studies including a meta-analysis showing a moderate effect. The research primarily involves adults, with some data in adults with cancer, but no consistent effective dose range has been established across studies.

Strongest evidence: The most researched outcome for Lactobacillus helveticus Rosell-52 is reduced depression symptoms, supported by 4 studies with low-strength evidence. A 2025 meta-analysis of 7 RCTs reported a statistically significant moderate reduction in depressive symptoms (SMD -0.55, p=0.03). No consistent effective dose range was identified across studies.

Mixed or weaker evidence: For improved cognitive function, 3 studies (low evidence strength) showed mixed effects. A single meta-analysis reported a large benefit in patients with depression (SMD -0.90, p=0.01), but two narrative reviews found only small, inconsistent benefits, particularly in healthy populations. For improved mental health, 3 reviews (low evidence strength) reported a small beneficial effect, though none were statistically significant.

Effective dose patterns: No cross-cutting dose insights could be drawn — none of the three syntheses reported a specific effective dose, as studies did not consistently report dose, form, or duration.

Population insights: The strongest evidence for depression symptoms comes from general adult populations and adults with cancer. Cognitive benefits appear more pronounced in patients with depression than in healthy individuals. No studies specifically examined elderly or deficient populations.

Notable caveats: All three evidence syntheses are rated low strength, with small numbers of studies (3-4 each). Publication bias is a concern in the depression literature — null results are less likely to be published. Only 1 of the 7 total studies across outcomes reported statistically significant findings, and most evidence comes from reviews or multi-strain formulations, making it difficult to isolate the effect of Rosell-52 specifically.

Frequently asked

  • What is Lactobacillus helveticus Rosell-52 good for according to research?
    Research has examined Lactobacillus helveticus Rosell-52 for three health outcomes: reducing depression symptoms, improving cognitive function, and improving overall mental health. The strongest evidence is for a moderate reduction in depression symptoms, based on 4 studies including a meta-analysis. Evidence for cognitive and general mental health benefits is weaker and more mixed.
  • What dose of Lactobacillus helveticus Rosell-52 is typically used in studies?
    No specific dose range, form, or study duration was consistently reported across the available research syntheses. None of the three outcomes had an identified effective dose, as primary studies often did not isolate single-strain dosing or report details clearly. Therefore, no evidence-based dose recommendation can be drawn from this research.
  • Who benefits most from Lactobacillus helveticus Rosell-52?
    For depression symptoms, research has primarily involved general adult populations and adults with cancer, with preliminary evidence suggesting benefit. For cognitive function, benefits were more pronounced in patients with depression (based on one meta-analysis) than in healthy populations with low baseline stress. General mental health research has focused on adult humans, but no specific subgroup has been identified as clearly benefiting most.
  • Does Lactobacillus helveticus Rosell-52 help with depression symptoms?
    A 2025 meta-analysis of 7 RCTs reported a statistically significant moderate reduction in depressive symptoms (SMD -0.55, p=0.03). Across 4 studies, all reported beneficial effects, though effect sizes ranged from small to moderate. The evidence is rated low strength due to a small number of studies and high heterogeneity (I² = 79%), and conclusions should be considered preliminary.
  • Are there caveats or limitations in the research on Lactobacillus helveticus Rosell-52?
    Yes. All evidence for this strain is rated low strength. The evidence base is small (3-4 studies per outcome) and conclusions are preliminary. Publication bias is a concern in the depression literature. Most studies used multi-strain formulations, making it hard to attribute benefits solely to Rosell-52. Many studies are reviews rather than primary trials, limiting causal inference.
  • What is the evidence strength rating for this probiotic strain?
    Across all three researched outcomes — reduced depression symptoms, improved cognitive function, and improved mental health — the evidence strength is rated as low. This is due to small numbers of studies, high heterogeneity in some analyses, lack of statistical significance in most individual studies, and reliance on reviews rather than direct clinical trials.

Most-studied combinations with Lactobacillus helveticus Rosell-52

most supplement research is combination research
  • Epic Pro 25-Strain Probiotic

    By Swanson

    4.6 (243 reviews)
    In Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $23.99
    In
    Vitacost
    $-
    Out
    Vitamin Shoppe
    $-
    Out
  • FLORASSIST Mood Improve

    By Life Extension

    4.6 (597 reviews)
    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $23.25
    In
    Vitacost
    $23.25
    In
    Vitamin Shoppe
    $-
    Out
  • Happy Mind

    By Swanson

    4.4 (19 reviews)
    Out of Stock
    Available From
    Available From
    MerchantPriceStockAction
    Amazon
    $-
    Out
    iHerb
    $19.99
    In
    Vitacost
    $-
    Out
    Vitamin Shoppe
    $-
    Out
Back to top